Global Pigmentation Disorders Treatment Market

Pigmentation Disorders Treatment Market is expected to reach US$ 10.5 Bn. at a CAGR of 7.2% during the forecast period 2029.

Pigmentation Disorders Treatment Market Overview:

Pigmentation disorders are skin tissue abnormalities that can be recognised, examined, and treated in primary care settings. When compared to the pre-existing skin colour, this disease can produce either skin lightening or skin darkening.To know about the Research Methodology :- Request Free Sample Report

Pigmentation Disorders Treatment Market Dynamics:

Increasing demand for skin lightening procedure is the major factor driving the market growth.

Rising up-gradation of lifestyle along with an increase in demand for skin lightening is a major factor expected to drive the global pigmentation problem treatment market. Melanin, a skin component produced by some specific cells in the body, regulates skin colour. Pigmentation is caused by damaged or diseased melanin-producing cells that produce too little or too much melanin. Melasma (hyperpigmentary disorder), vitiligo (hypopigmentary disorder), albinism (inherited uncommon disorder), and post-inflammatory hyperpigmentation are the most frequent pigmentation diseases.

Environmental changes, such as global warming, have a substantial impact on the skin and are expected to aid the industry's growth in the next years. Furthermore, advancements in tissue engineering, as well as a spike in fresh methods for boosting aesthetics and skincare products, will aid the industry in achieving maximum revenue in the near future. Other factors driving the global pigmentation problem treatment market include an ageing population, an increase in the frequency of skin problems, and rising disposable income. Growing consumer knowledge of cosmeceutical and cosmetics goods, such as anti-aging, sun care, and hair care, and beauty, is predicted to improve the industry's growth potential in the future. The introduction of natural and plant-based components has been critical in meeting the global demand for cosmeceutical products. The exorbitant expenses of cosmetic treatments and surgery, on the other hand, are limiting the market growth.

The report has profiled nineteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Pigmentation Disorders Treatment Market Segment Analysis:

The Global Pigmentation Disorders Treatment Market is segmented on the basis of Type of Disorder, Treatment and Distribution Channel.

Based on Type of Disorder, the Melasma segment is dominating the global market. Melasma is currently leading the illness type sector because of its high incidence rate in the Caucasian population, which accounts for 55% to 60% of the global population. Melasma affects 90% of women worldwide, and it is caused by hormonal fluctuations, pregnancy, and birth control drugs.

Based on Treatment, the Topical Treatment segment is expected to grow at a significant CAGR of XX% during the forecast period. Due to improved clinical outcomes in individuals with pigmentation disorders, topical therapy is currently dominating the global market. Azelaic acid, hydroquinone, L-ascorbic acid, and other topical medicines are the most commonly recommended worldwide. Due to the highest occurrence of melasma in the white population, topical therapy comprises hydroquinone as a first-line drug, as well as a retinoid. According to the National Clinical Trials (NCT) registry, Incyte Corporation is conducting a phase II clinical trial for Ruxolitinib in the treatment of Vitiligo in the United States as of June 18, 2020. If Ruxolitinib is approved for the treatment of Vitiligo in the near future, this aspect will raise the market.

Pigmentation Disorders Treatment Market Regional Insights:

North America is expected to hold the dominant market share during forecast period.

Because of the increased prevalence of pigmentation disorders, North America dominates the global pigmentation disorders treatment market. In North America, there is a well-established healthcare infrastructure and large market companies that provide efficient treatment choices for patients with post-inflammatory hyperpigmentation. Due to increased beauty concern among Asians, rapid entry of new competitors into the market, and growth by major companies into emerging economies, the Asia Pacific region is witnessing a quick pace in the global pigmentation disorders treatment market.

The report also helps in understanding Global Pigmentation Disorders Treatment Market dynamics, structure by analyzing the market segments and project the Global Pigmentation Disorders Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pigmentation Disorders Treatment Market make the report investor’s guide.

Pigmentation Disorders Treatment Market Scope: Inquire before buying

Global Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Global Pigmentation Disorders Treatment Market, Key players:

1. Episciences, Inc.
2. La Roche-Posay
3. Bayer AG
4. Allergan, Inc.
5. SkinCeuticals International
6. Pierre Fabre Laboratories
7. Alvogen, Inc.
8. Obagi Medical Products Inc.
9. CLINUVEL PHARMACEUTICALS LTD
10.Clarify Medical, Inc
11.Incyte Corporation
12.Dr. Reddy’s Laboratories Ltd
13.Glenmark Pharmaceuticals Ltd
14.Teva Pharmaceutical Industries Ltd
15.Bausch Health
16.Novartis AG
17.Mylan N.V.
18.Pfizer Inc
19.Panacea Biotec Ltd

Frequently Asked Questions:

1. Which region has the largest share in Global Pigmentation Disorders Treatment Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Pigmentation Disorders Treatment Market?
Ans: The Global Pigmentation Disorders Treatment Market is growing at a CAGR of 7.2% during forecasting period 2023-2029.

3. What is scope of the Global Pigmentation Disorders Treatment Market report?
Ans: Global Pigmentation Disorders Treatment Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Pigmentation Disorders Treatment Market?
Ans: The important key players in the Global Pigmentation Disorders Treatment Market are – Episciences, Inc., La Roche-Posay, Bayer AG, Allergan, Inc., SkinCeuticals International, Pierre Fabre Laboratories, Alvogen, Inc., Obagi Medical Products Inc., CLINUVEL PHARMACEUTICALS LTD, Clarify Medical, Inc, Incyte Corporation, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd, Bausch Health, Novartis AG, Mylan N.V., Pfizer Inc, Panacea Biotec Ltd.

5. What is the study period of this Market?
Ans: The Global Pigmentation Disorders Treatment Market is studied from 2022 to 2029.